EKSO
Ekso Bionics Holdings, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$15.90
−9.86%Year over year
Reported trailing growth
- Revenue
- -34.1%
- EBITDA
- -34.5%
- EBIT
- -45.7%
- EPS
- —
- Free cash flow
- -42.8%
- Operating cash flow
- -43.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.3%
- EBITDA
- -3.8%
- EBIT
- -27.4%
- Net income
- -3.2%
- EPS
- +41.8%
- Free cash flow
- -21.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026